VBIV - VBI Vaccines Inc.
Previous close
0.0653
0 0%
Share volume: 294,352
Last Updated: Wed 07 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.07
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-09 | 2022-08-08 | 2022-11-10 | 2023-03-13 | 2023-05-15 | 2023-08-14 | 2023-11-14 | |
| Cash flow financing | 12.000 K | 11.988 M | 19.437 M | 0.000 | 0.000 | 0.000 | 22.426 B | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -19.925 M | -37.355 B | -17.274 M | -19.046 M | -21.656 M | -40.844 B | -7.960 B | |
| Net income | -21.254 M | -45.699 M | -25.209 M | -21.141 M | -27.751 M | -44.628 M | -21.306 M | |
| Depreciation | 473.000 K | 1.015 B | 526.000 K | 520.000 K | 508.000 K | 1.017 B | 498.000 M | |
| Changes in inventories | 4.057 M | 4.050 M | 5.796 M | 6.599 M | 6.768 M | 6.861 M | 7.540 M | |
| Changes in receivables | 2.871 M | 2.448 M | 2.482 M | 4.127 M | 281.000 K | 79.000 K | 3.823 M | |
| Investing Cashflow | -515.000 K | -1.591 B | -1.300 M | -1.452 M | -534.000 K | -583.466 M | -113.000 M | |
| Net Borrowings | -75.887 M | -56.311 M | -39.520 M | -18.076 M | 4.572 M | 24.878 M | 11.515 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -515.000 K | -1.591 B | -1.300 M | -1.452 M | -534.000 K | -583.466 M | -113.000 M | |
| Cash Change | 101.337 M | 82.414 M | 83.550 M | 62.629 M | 40.392 M | 20.840 M | 35.454 M |